nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC15A2—melanoma	0.779	1	CbGaD
Valaciclovir—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00955	0.117	CbGpPWpGaD
Valaciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.00547	0.0667	CbGpPWpGaD
Valaciclovir—Valganciclovir—SLC15A2—melanoma	0.00389	1	CrCbGaD
Valaciclovir—SLC6A14—Amine compound SLC transporters—SLC6A11—melanoma	0.00379	0.0463	CbGpPWpGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00293	0.0358	CbGpPWpGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00282	0.0344	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC39A12—melanoma	0.00233	0.0284	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—ARL2—melanoma	0.00232	0.0283	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.00173	0.0211	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.00166	0.0203	CbGpPWpGaD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—melanoma	0.0015	0.0183	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.00148	0.0181	CbGpPWpGaD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00133	0.0163	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	0.00133	0.0162	CbGpPWpGaD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00129	0.0157	CbGpPWpGaD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00124	0.0151	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	0.00123	0.015	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	0.00122	0.0149	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	0.00121	0.0148	CbGpPWpGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00117	0.0143	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—EPHA2—melanoma	0.00114	0.0139	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC6A11—melanoma	0.00107	0.0131	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—melanoma	0.000893	0.0109	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000831	0.0101	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000816	0.00996	CbGpPWpGaD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000786	0.00959	CbGpPWpGaD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—melanoma	0.000782	0.00954	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000771	0.00941	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000758	0.00925	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB5—melanoma	0.000746	0.00911	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000742	0.00906	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000729	0.0089	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.00069	0.00842	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000674	0.00823	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00065	0.00794	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	0.000644	0.00786	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000593	0.00439	CcSEcCtD
Valaciclovir—Haematuria—Bleomycin—melanoma	0.00059	0.00437	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000579	0.00707	CbGpPWpGaD
Valaciclovir—Decreased appetite—Vemurafenib—melanoma	0.000566	0.00419	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000565	0.0069	CbGpPWpGaD
Valaciclovir—Bronchitis—Temozolomide—melanoma	0.000563	0.00417	CcSEcCtD
Valaciclovir—Stomatitis—Dactinomycin—melanoma	0.000562	0.00417	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000562	0.00416	CcSEcCtD
Valaciclovir—Fatigue—Vemurafenib—melanoma	0.000561	0.00416	CcSEcCtD
Valaciclovir—Constipation—Vemurafenib—melanoma	0.000557	0.00412	CcSEcCtD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000554	0.00676	CbGpPWpGaD
Valaciclovir—Upper respiratory tract infection—Temozolomide—melanoma	0.000544	0.00403	CcSEcCtD
Valaciclovir—Depression—Carmustine—melanoma	0.000538	0.00399	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Temozolomide—melanoma	0.000534	0.00396	CcSEcCtD
Valaciclovir—Renal failure—Carmustine—melanoma	0.000531	0.00393	CcSEcCtD
Valaciclovir—Stomatitis—Carmustine—melanoma	0.000526	0.0039	CcSEcCtD
Valaciclovir—Urinary tract infection—Carmustine—melanoma	0.000525	0.00389	CcSEcCtD
Valaciclovir—Depression—Temozolomide—melanoma	0.00052	0.00385	CcSEcCtD
Valaciclovir—Hepatitis—Dactinomycin—melanoma	0.000518	0.00384	CcSEcCtD
Valaciclovir—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000518	0.00383	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ARL2—melanoma	0.000517	0.00631	CbGpPWpGaD
Valaciclovir—Body temperature increased—Vemurafenib—melanoma	0.000515	0.00381	CcSEcCtD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000514	0.00628	CbGpPWpGaD
Valaciclovir—Pharyngitis—Dactinomycin—melanoma	0.000514	0.00381	CcSEcCtD
Valaciclovir—Stomatitis—Temozolomide—melanoma	0.000509	0.00377	CcSEcCtD
Valaciclovir—Urinary tract infection—Temozolomide—melanoma	0.000507	0.00376	CcSEcCtD
Valaciclovir—Chills—Bleomycin—melanoma	0.000498	0.00369	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Temozolomide—melanoma	0.000494	0.00366	CcSEcCtD
Valaciclovir—Alopecia—Bleomycin—melanoma	0.000491	0.00363	CcSEcCtD
Valaciclovir—Erythema multiforme—Dactinomycin—melanoma	0.00049	0.00363	CcSEcCtD
Valaciclovir—Sinusitis—Temozolomide—melanoma	0.00049	0.00363	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SLC5A5—melanoma	0.000489	0.00597	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000483	0.0059	CbGpPWpGaD
Valaciclovir—Hallucination—Carmustine—melanoma	0.000482	0.00357	CcSEcCtD
Valaciclovir—Hypersensitivity—Vemurafenib—melanoma	0.00048	0.00355	CcSEcCtD
Valaciclovir—Oedema peripheral—Carmustine—melanoma	0.000478	0.00354	CcSEcCtD
Valaciclovir—Renal impairment—Docetaxel—melanoma	0.000473	0.0035	CcSEcCtD
Valaciclovir—Hepatitis—Temozolomide—melanoma	0.000468	0.00347	CcSEcCtD
Valaciclovir—Asthenia—Vemurafenib—melanoma	0.000467	0.00346	CcSEcCtD
Valaciclovir—Hallucination—Temozolomide—melanoma	0.000466	0.00345	CcSEcCtD
Valaciclovir—Pharyngitis—Temozolomide—melanoma	0.000465	0.00344	CcSEcCtD
Valaciclovir—Chills—Dactinomycin—melanoma	0.000465	0.00344	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	0.000463	0.00565	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Temozolomide—melanoma	0.000463	0.00343	CcSEcCtD
Valaciclovir—Oedema peripheral—Temozolomide—melanoma	0.000461	0.00342	CcSEcCtD
Valaciclovir—Pruritus—Vemurafenib—melanoma	0.000461	0.00341	CcSEcCtD
Valaciclovir—Urethral disorder—Temozolomide—melanoma	0.000459	0.0034	CcSEcCtD
Valaciclovir—Alopecia—Dactinomycin—melanoma	0.000458	0.00339	CcSEcCtD
Valaciclovir—Anaemia—Bleomycin—melanoma	0.000447	0.00331	CcSEcCtD
Valaciclovir—Diarrhoea—Vemurafenib—melanoma	0.000446	0.0033	CcSEcCtD
Valaciclovir—Migraine—Docetaxel—melanoma	0.000443	0.00328	CcSEcCtD
Valaciclovir—Erythema multiforme—Temozolomide—melanoma	0.000443	0.00328	CcSEcCtD
Valaciclovir—Leukopenia—Bleomycin—melanoma	0.000433	0.00321	CcSEcCtD
Valaciclovir—Dizziness—Vemurafenib—melanoma	0.000431	0.00319	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000429	0.00523	CbGpPWpGaD
Valaciclovir—Alopecia—Carmustine—melanoma	0.000428	0.00317	CcSEcCtD
Valaciclovir—Ataxia—Docetaxel—melanoma	0.000423	0.00314	CcSEcCtD
Valaciclovir—Immune system disorder—Temozolomide—melanoma	0.000423	0.00313	CcSEcCtD
Valaciclovir—Mediastinal disorder—Temozolomide—melanoma	0.000422	0.00313	CcSEcCtD
Valaciclovir—Cough—Bleomycin—melanoma	0.000422	0.00312	CcSEcCtD
Valaciclovir—Chills—Temozolomide—melanoma	0.00042	0.00311	CcSEcCtD
Valaciclovir—Dehydration—Docetaxel—melanoma	0.000419	0.0031	CcSEcCtD
Valaciclovir—Anaemia—Dactinomycin—melanoma	0.000417	0.00309	CcSEcCtD
Valaciclovir—Liver function test abnormal—Docetaxel—melanoma	0.000416	0.00308	CcSEcCtD
Valaciclovir—Vomiting—Vemurafenib—melanoma	0.000414	0.00307	CcSEcCtD
Valaciclovir—Alopecia—Temozolomide—melanoma	0.000414	0.00307	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000413	0.00503	CbGpPWpGaD
Valaciclovir—Chest pain—Bleomycin—melanoma	0.000412	0.00305	CcSEcCtD
Valaciclovir—Myalgia—Bleomycin—melanoma	0.000412	0.00305	CcSEcCtD
Valaciclovir—Rash—Vemurafenib—melanoma	0.000411	0.00304	CcSEcCtD
Valaciclovir—Dermatitis—Vemurafenib—melanoma	0.00041	0.00304	CcSEcCtD
Valaciclovir—Back pain—Carmustine—melanoma	0.000408	0.00302	CcSEcCtD
Valaciclovir—Headache—Vemurafenib—melanoma	0.000408	0.00302	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000406	0.003	CcSEcCtD
Valaciclovir—Leukopenia—Dactinomycin—melanoma	0.000404	0.00299	CcSEcCtD
Valaciclovir—Nasopharyngitis—Docetaxel—melanoma	0.000403	0.00298	CcSEcCtD
Valaciclovir—Confusional state—Bleomycin—melanoma	0.000398	0.00295	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Docetaxel—melanoma	0.000397	0.00294	CcSEcCtD
Valaciclovir—Tremor—Carmustine—melanoma	0.000395	0.00293	CcSEcCtD
Valaciclovir—Anaphylactic shock—Bleomycin—melanoma	0.000395	0.00292	CcSEcCtD
Valaciclovir—Oedema—Bleomycin—melanoma	0.000395	0.00292	CcSEcCtD
Valaciclovir—Back pain—Temozolomide—melanoma	0.000394	0.00292	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000394	0.00481	CbGpPWpGaD
Valaciclovir—Infection—Bleomycin—melanoma	0.000392	0.0029	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000392	0.00478	CbGpPWpGaD
Valaciclovir—Anaemia—Carmustine—melanoma	0.00039	0.00289	CcSEcCtD
Valaciclovir—Agitation—Carmustine—melanoma	0.000388	0.00287	CcSEcCtD
Valaciclovir—Nausea—Vemurafenib—melanoma	0.000387	0.00287	CcSEcCtD
Valaciclovir—Thrombocytopenia—Bleomycin—melanoma	0.000386	0.00286	CcSEcCtD
Valaciclovir—Myalgia—Dactinomycin—melanoma	0.000384	0.00284	CcSEcCtD
Valaciclovir—Tremor—Temozolomide—melanoma	0.000382	0.00283	CcSEcCtD
Valaciclovir—Leukopenia—Carmustine—melanoma	0.000378	0.0028	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000377	0.00461	CbGpPWpGaD
Valaciclovir—Anaemia—Temozolomide—melanoma	0.000377	0.00279	CcSEcCtD
Valaciclovir—Anorexia—Bleomycin—melanoma	0.000376	0.00279	CcSEcCtD
Valaciclovir—Agitation—Temozolomide—melanoma	0.000375	0.00278	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000375	0.00457	CbGpPWpGaD
Valaciclovir—Angioedema—Temozolomide—melanoma	0.000373	0.00276	CcSEcCtD
Valaciclovir—Oedema—Dactinomycin—melanoma	0.000368	0.00273	CcSEcCtD
Valaciclovir—Convulsion—Carmustine—melanoma	0.000366	0.00271	CcSEcCtD
Valaciclovir—Infection—Dactinomycin—melanoma	0.000366	0.00271	CcSEcCtD
Valaciclovir—Leukopenia—Temozolomide—melanoma	0.000365	0.0027	CcSEcCtD
Valaciclovir—Hypertension—Carmustine—melanoma	0.000364	0.0027	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—HGF—melanoma	0.000362	0.00442	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Dactinomycin—melanoma	0.00036	0.00267	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000359	0.00266	CcSEcCtD
Valaciclovir—Chest pain—Carmustine—melanoma	0.000359	0.00266	CcSEcCtD
Valaciclovir—Myalgia—Carmustine—melanoma	0.000359	0.00266	CcSEcCtD
Valaciclovir—Cough—Temozolomide—melanoma	0.000356	0.00264	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	0.000354	0.00433	CbGpPWpGaD
Valaciclovir—Paraesthesia—Bleomycin—melanoma	0.000354	0.00262	CcSEcCtD
Valaciclovir—Convulsion—Temozolomide—melanoma	0.000353	0.00262	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000353	0.00431	CbGpPWpGaD
Valaciclovir—Hypertension—Temozolomide—melanoma	0.000352	0.00261	CcSEcCtD
Valaciclovir—Dyspnoea—Bleomycin—melanoma	0.000352	0.00261	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000351	0.00429	CbGpPWpGaD
Valaciclovir—Anorexia—Dactinomycin—melanoma	0.000351	0.0026	CcSEcCtD
Valaciclovir—Confusional state—Carmustine—melanoma	0.000347	0.00257	CcSEcCtD
Valaciclovir—Arthralgia—Temozolomide—melanoma	0.000347	0.00257	CcSEcCtD
Valaciclovir—Myalgia—Temozolomide—melanoma	0.000347	0.00257	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000345	0.00255	CcSEcCtD
Valaciclovir—Oedema—Carmustine—melanoma	0.000344	0.00255	CcSEcCtD
Valaciclovir—Decreased appetite—Bleomycin—melanoma	0.000343	0.00254	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000343	0.00418	CbGpPWpGaD
Valaciclovir—Infection—Carmustine—melanoma	0.000342	0.00253	CcSEcCtD
Valaciclovir—Renal failure—Docetaxel—melanoma	0.000341	0.00253	CcSEcCtD
Valaciclovir—Dry mouth—Temozolomide—melanoma	0.00034	0.00251	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000339	0.00413	CbGpPWpGaD
Valaciclovir—Stomatitis—Docetaxel—melanoma	0.000338	0.00251	CcSEcCtD
Valaciclovir—Pain—Bleomycin—melanoma	0.000337	0.0025	CcSEcCtD
Valaciclovir—Thrombocytopenia—Carmustine—melanoma	0.000337	0.0025	CcSEcCtD
Valaciclovir—Tachycardia—Carmustine—melanoma	0.000336	0.00249	CcSEcCtD
Valaciclovir—Confusional state—Temozolomide—melanoma	0.000336	0.00249	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000335	0.00248	CcSEcCtD
Valaciclovir—Oedema—Temozolomide—melanoma	0.000333	0.00247	CcSEcCtD
Valaciclovir—Anaphylactic shock—Temozolomide—melanoma	0.000333	0.00247	CcSEcCtD
Valaciclovir—Infection—Temozolomide—melanoma	0.000331	0.00245	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000329	0.00401	CbGpPWpGaD
Valaciclovir—Anorexia—Carmustine—melanoma	0.000328	0.00243	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Docetaxel—melanoma	0.000328	0.00243	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000328	0.004	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Temozolomide—melanoma	0.000326	0.00242	CcSEcCtD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000326	0.00398	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000326	0.00398	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Temozolomide—melanoma	0.000326	0.00241	CcSEcCtD
Valaciclovir—Feeling abnormal—Bleomycin—melanoma	0.000325	0.00241	CcSEcCtD
Valaciclovir—Skin disorder—Temozolomide—melanoma	0.000323	0.00239	CcSEcCtD
Valaciclovir—Decreased appetite—Dactinomycin—melanoma	0.00032	0.00237	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000319	0.00389	CbGpPWpGaD
Valaciclovir—Fatigue—Dactinomycin—melanoma	0.000317	0.00235	CcSEcCtD
Valaciclovir—Anorexia—Temozolomide—melanoma	0.000317	0.00235	CcSEcCtD
Valaciclovir—Pain—Dactinomycin—melanoma	0.000315	0.00233	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Carmustine—melanoma	0.000314	0.00232	CcSEcCtD
Valaciclovir—Urticaria—Bleomycin—melanoma	0.000313	0.00232	CcSEcCtD
Valaciclovir—Rhinitis—Docetaxel—melanoma	0.000312	0.00231	CcSEcCtD
Valaciclovir—Body temperature increased—Bleomycin—melanoma	0.000312	0.00231	CcSEcCtD
Valaciclovir—Hepatitis—Docetaxel—melanoma	0.000312	0.00231	CcSEcCtD
Valaciclovir—Insomnia—Carmustine—melanoma	0.000312	0.00231	CcSEcCtD
Valaciclovir—Paraesthesia—Carmustine—melanoma	0.000309	0.00229	CcSEcCtD
Valaciclovir—Pharyngitis—Docetaxel—melanoma	0.000309	0.00229	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000308	0.00376	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Docetaxel—melanoma	0.000308	0.00228	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000308	0.00375	CbGpPWpGaD
Valaciclovir—Dyspnoea—Carmustine—melanoma	0.000307	0.00227	CcSEcCtD
Valaciclovir—Oedema peripheral—Docetaxel—melanoma	0.000307	0.00227	CcSEcCtD
Valaciclovir—Somnolence—Carmustine—melanoma	0.000306	0.00227	CcSEcCtD
Valaciclovir—Urethral disorder—Docetaxel—melanoma	0.000305	0.00226	CcSEcCtD
Valaciclovir—Feeling abnormal—Dactinomycin—melanoma	0.000303	0.00225	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000303	0.00225	CcSEcCtD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000303	0.0037	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000301	0.00368	CbGpPWpGaD
Valaciclovir—Insomnia—Temozolomide—melanoma	0.000301	0.00223	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Dactinomycin—melanoma	0.000301	0.00223	CcSEcCtD
Valaciclovir—Decreased appetite—Carmustine—melanoma	0.000299	0.00222	CcSEcCtD
Valaciclovir—Paraesthesia—Temozolomide—melanoma	0.000299	0.00221	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Carmustine—melanoma	0.000297	0.0022	CcSEcCtD
Valaciclovir—Dyspnoea—Temozolomide—melanoma	0.000297	0.0022	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000296	0.00361	CbGpPWpGaD
Valaciclovir—Somnolence—Temozolomide—melanoma	0.000296	0.00219	CcSEcCtD
Valaciclovir—Erythema multiforme—Docetaxel—melanoma	0.000295	0.00218	CcSEcCtD
Valaciclovir—Pain—Carmustine—melanoma	0.000295	0.00218	CcSEcCtD
Valaciclovir—Constipation—Carmustine—melanoma	0.000295	0.00218	CcSEcCtD
Valaciclovir—Dyspepsia—Temozolomide—melanoma	0.000293	0.00217	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB5—melanoma	0.000291	0.00356	CbGpPWpGaD
Valaciclovir—Abdominal pain—Dactinomycin—melanoma	0.000291	0.00215	CcSEcCtD
Valaciclovir—Body temperature increased—Dactinomycin—melanoma	0.000291	0.00215	CcSEcCtD
Valaciclovir—Hypersensitivity—Bleomycin—melanoma	0.000291	0.00215	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00029	0.00354	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACER3—melanoma	0.00029	0.00353	CbGpPWpGaD
Valaciclovir—Decreased appetite—Temozolomide—melanoma	0.000289	0.00214	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Temozolomide—melanoma	0.000287	0.00213	CcSEcCtD
Valaciclovir—Fatigue—Temozolomide—melanoma	0.000287	0.00213	CcSEcCtD
Valaciclovir—Pain—Temozolomide—melanoma	0.000285	0.00211	CcSEcCtD
Valaciclovir—Constipation—Temozolomide—melanoma	0.000285	0.00211	CcSEcCtD
Valaciclovir—Feeling abnormal—Carmustine—melanoma	0.000284	0.0021	CcSEcCtD
Valaciclovir—Asthenia—Bleomycin—melanoma	0.000283	0.0021	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Carmustine—melanoma	0.000282	0.00209	CcSEcCtD
Valaciclovir—Immune system disorder—Docetaxel—melanoma	0.000281	0.00208	CcSEcCtD
Valaciclovir—Mediastinal disorder—Docetaxel—melanoma	0.000281	0.00208	CcSEcCtD
Valaciclovir—Chills—Docetaxel—melanoma	0.00028	0.00207	CcSEcCtD
Valaciclovir—Pruritus—Bleomycin—melanoma	0.000279	0.00207	CcSEcCtD
Valaciclovir—Alopecia—Docetaxel—melanoma	0.000275	0.00204	CcSEcCtD
Valaciclovir—Feeling abnormal—Temozolomide—melanoma	0.000274	0.00203	CcSEcCtD
Valaciclovir—Body temperature increased—Carmustine—melanoma	0.000272	0.00202	CcSEcCtD
Valaciclovir—Abdominal pain—Carmustine—melanoma	0.000272	0.00202	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Temozolomide—melanoma	0.000272	0.00202	CcSEcCtD
Valaciclovir—Hypersensitivity—Dactinomycin—melanoma	0.000271	0.00201	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—UGT2B10—melanoma	0.000265	0.00323	CbGpPWpGaD
Valaciclovir—Urticaria—Temozolomide—melanoma	0.000264	0.00196	CcSEcCtD
Valaciclovir—Asthenia—Dactinomycin—melanoma	0.000264	0.00196	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000263	0.00321	CbGpPWpGaD
Valaciclovir—Body temperature increased—Temozolomide—melanoma	0.000263	0.00195	CcSEcCtD
Valaciclovir—Abdominal pain—Temozolomide—melanoma	0.000263	0.00195	CcSEcCtD
Valaciclovir—Back pain—Docetaxel—melanoma	0.000262	0.00194	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000261	0.00319	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Carmustine—melanoma	0.000254	0.00188	CcSEcCtD
Valaciclovir—Diarrhoea—Dactinomycin—melanoma	0.000252	0.00186	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000251	0.00307	CbGpPWpGaD
Valaciclovir—Vomiting—Bleomycin—melanoma	0.000251	0.00186	CcSEcCtD
Valaciclovir—Anaemia—Docetaxel—melanoma	0.000251	0.00186	CcSEcCtD
Valaciclovir—Rash—Bleomycin—melanoma	0.000249	0.00184	CcSEcCtD
Valaciclovir—Dermatitis—Bleomycin—melanoma	0.000249	0.00184	CcSEcCtD
Valaciclovir—Asthenia—Carmustine—melanoma	0.000247	0.00183	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HS3ST5—melanoma	0.000246	0.00301	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Temozolomide—melanoma	0.000245	0.00182	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000245	0.00299	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	0.000243	0.00297	CbGpPWpGaD
Valaciclovir—Leukopenia—Docetaxel—melanoma	0.000243	0.0018	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000242	0.00295	CbGpPWpGaD
Valaciclovir—Asthenia—Temozolomide—melanoma	0.000239	0.00177	CcSEcCtD
Valaciclovir—Cough—Docetaxel—melanoma	0.000237	0.00175	CcSEcCtD
Valaciclovir—Diarrhoea—Carmustine—melanoma	0.000236	0.00175	CcSEcCtD
Valaciclovir—Pruritus—Temozolomide—melanoma	0.000235	0.00174	CcSEcCtD
Valaciclovir—Convulsion—Docetaxel—melanoma	0.000235	0.00174	CcSEcCtD
Valaciclovir—Nausea—Bleomycin—melanoma	0.000234	0.00174	CcSEcCtD
Valaciclovir—Hypertension—Docetaxel—melanoma	0.000234	0.00173	CcSEcCtD
Valaciclovir—Vomiting—Dactinomycin—melanoma	0.000234	0.00173	CcSEcCtD
Valaciclovir—Rash—Dactinomycin—melanoma	0.000232	0.00172	CcSEcCtD
Valaciclovir—Myalgia—Docetaxel—melanoma	0.000231	0.00171	CcSEcCtD
Valaciclovir—Chest pain—Docetaxel—melanoma	0.000231	0.00171	CcSEcCtD
Valaciclovir—Arthralgia—Docetaxel—melanoma	0.000231	0.00171	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000229	0.0017	CcSEcCtD
Valaciclovir—Dizziness—Carmustine—melanoma	0.000228	0.00169	CcSEcCtD
Valaciclovir—Diarrhoea—Temozolomide—melanoma	0.000228	0.00169	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000227	0.00277	CbGpPWpGaD
Valaciclovir—Dry mouth—Docetaxel—melanoma	0.000226	0.00167	CcSEcCtD
Valaciclovir—Confusional state—Docetaxel—melanoma	0.000223	0.00165	CcSEcCtD
Valaciclovir—Anaphylactic shock—Docetaxel—melanoma	0.000221	0.00164	CcSEcCtD
Valaciclovir—Oedema—Docetaxel—melanoma	0.000221	0.00164	CcSEcCtD
Valaciclovir—Dizziness—Temozolomide—melanoma	0.00022	0.00163	CcSEcCtD
Valaciclovir—Infection—Docetaxel—melanoma	0.00022	0.00163	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00022	0.00268	CbGpPWpGaD
Valaciclovir—Vomiting—Carmustine—melanoma	0.000219	0.00162	CcSEcCtD
Valaciclovir—Nausea—Dactinomycin—melanoma	0.000219	0.00162	CcSEcCtD
Valaciclovir—Rash—Carmustine—melanoma	0.000217	0.00161	CcSEcCtD
Valaciclovir—Nervous system disorder—Docetaxel—melanoma	0.000217	0.00161	CcSEcCtD
Valaciclovir—Dermatitis—Carmustine—melanoma	0.000217	0.00161	CcSEcCtD
Valaciclovir—Thrombocytopenia—Docetaxel—melanoma	0.000217	0.00161	CcSEcCtD
Valaciclovir—Tachycardia—Docetaxel—melanoma	0.000216	0.0016	CcSEcCtD
Valaciclovir—Headache—Carmustine—melanoma	0.000216	0.0016	CcSEcCtD
Valaciclovir—Skin disorder—Docetaxel—melanoma	0.000215	0.00159	CcSEcCtD
Valaciclovir—Vomiting—Temozolomide—melanoma	0.000212	0.00157	CcSEcCtD
Valaciclovir—Anorexia—Docetaxel—melanoma	0.000211	0.00156	CcSEcCtD
Valaciclovir—Rash—Temozolomide—melanoma	0.00021	0.00155	CcSEcCtD
Valaciclovir—Dermatitis—Temozolomide—melanoma	0.00021	0.00155	CcSEcCtD
Valaciclovir—Headache—Temozolomide—melanoma	0.000209	0.00154	CcSEcCtD
Valaciclovir—Nausea—Carmustine—melanoma	0.000205	0.00152	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ARL2—melanoma	0.000202	0.00246	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000202	0.00149	CcSEcCtD
Valaciclovir—Insomnia—Docetaxel—melanoma	0.0002	0.00148	CcSEcCtD
Valaciclovir—Paraesthesia—Docetaxel—melanoma	0.000199	0.00147	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000198	0.00242	CbGpPWpGaD
Valaciclovir—Nausea—Temozolomide—melanoma	0.000198	0.00146	CcSEcCtD
Valaciclovir—Dyspnoea—Docetaxel—melanoma	0.000197	0.00146	CcSEcCtD
Valaciclovir—Somnolence—Docetaxel—melanoma	0.000197	0.00146	CcSEcCtD
Valaciclovir—Dyspepsia—Docetaxel—melanoma	0.000195	0.00144	CcSEcCtD
Valaciclovir—Decreased appetite—Docetaxel—melanoma	0.000192	0.00143	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Docetaxel—melanoma	0.000191	0.00142	CcSEcCtD
Valaciclovir—Fatigue—Docetaxel—melanoma	0.000191	0.00141	CcSEcCtD
Valaciclovir—Pain—Docetaxel—melanoma	0.000189	0.0014	CcSEcCtD
Valaciclovir—Constipation—Docetaxel—melanoma	0.000189	0.0014	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PLCB4—melanoma	0.000187	0.00228	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000183	0.00224	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Docetaxel—melanoma	0.000182	0.00135	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Docetaxel—melanoma	0.000181	0.00134	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000178	0.00218	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIP4K2A—melanoma	0.000175	0.00214	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC6A11—melanoma	0.000175	0.00214	CbGpPWpGaD
Valaciclovir—Body temperature increased—Docetaxel—melanoma	0.000175	0.0013	CcSEcCtD
Valaciclovir—Abdominal pain—Docetaxel—melanoma	0.000175	0.0013	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000172	0.0021	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000171	0.00209	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTAP—melanoma	0.000171	0.00208	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	0.000169	0.00206	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000167	0.00204	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000166	0.00202	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Docetaxel—melanoma	0.000163	0.00121	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000162	0.00198	CbGpPWpGaD
Valaciclovir—Asthenia—Docetaxel—melanoma	0.000159	0.00118	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000157	0.00191	CbGpPWpGaD
Valaciclovir—Pruritus—Docetaxel—melanoma	0.000157	0.00116	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000153	0.00187	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LUM—melanoma	0.000152	0.00186	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PHGDH—melanoma	0.000152	0.00186	CbGpPWpGaD
Valaciclovir—Diarrhoea—Docetaxel—melanoma	0.000151	0.00112	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00015	0.00184	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPSE—melanoma	0.000149	0.00182	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000147	0.0018	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—melanoma	0.000147	0.00179	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CUBN—melanoma	0.000146	0.00179	CbGpPWpGaD
Valaciclovir—Dizziness—Docetaxel—melanoma	0.000146	0.00108	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000146	0.00178	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SDHD—melanoma	0.000141	0.00173	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BSG—melanoma	0.000141	0.00173	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CSPG4—melanoma	0.000141	0.00173	CbGpPWpGaD
Valaciclovir—Vomiting—Docetaxel—melanoma	0.000141	0.00104	CcSEcCtD
Valaciclovir—Rash—Docetaxel—melanoma	0.00014	0.00103	CcSEcCtD
Valaciclovir—Dermatitis—Docetaxel—melanoma	0.000139	0.00103	CcSEcCtD
Valaciclovir—Headache—Docetaxel—melanoma	0.000139	0.00103	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GPAM—melanoma	0.000137	0.00167	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000135	0.00165	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000134	0.00163	CbGpPWpGaD
Valaciclovir—Nausea—Docetaxel—melanoma	0.000131	0.000974	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000131	0.00159	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000128	0.00156	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000123	0.0015	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00012	0.00147	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—melanoma	0.000119	0.00146	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLA2G6—melanoma	0.000116	0.00142	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000112	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—VCAN—melanoma	0.000105	0.00128	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.0001	0.00123	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.9e-05	0.00121	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.56e-05	0.00117	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP17A1—melanoma	8.83e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.7e-05	0.00106	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.59e-05	0.00105	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GNA11—melanoma	8.33e-05	0.00102	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—melanoma	8.17e-05	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FASN—melanoma	8.16e-05	0.000996	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC5A5—melanoma	8.02e-05	0.000979	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GNAQ—melanoma	7.75e-05	0.000946	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CD44—melanoma	7.75e-05	0.000946	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.59e-05	0.000926	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.52e-05	0.000918	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—melanoma	7.47e-05	0.000912	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1B1—melanoma	7.43e-05	0.000907	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	7.41e-05	0.000904	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	6.96e-05	0.000849	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	6.88e-05	0.000839	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.56e-05	0.0008	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	6.46e-05	0.000788	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCB1—melanoma	6.12e-05	0.000747	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	6.12e-05	0.000747	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	5.74e-05	0.000701	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	5.65e-05	0.00069	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PRKCA—melanoma	5.63e-05	0.000687	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ERCC2—melanoma	5.58e-05	0.000682	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	5.24e-05	0.00064	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	5.1e-05	0.000623	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	4.79e-05	0.000585	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	4.66e-05	0.000569	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.63e-05	0.000565	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—melanoma	4.41e-05	0.000538	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—melanoma	4.26e-05	0.000519	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	3.89e-05	0.000475	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—melanoma	3.88e-05	0.000473	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—melanoma	3.83e-05	0.000467	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	3.53e-05	0.000431	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—melanoma	3.38e-05	0.000412	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—melanoma	3.35e-05	0.000409	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	3.28e-05	0.0004	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—melanoma	2.92e-05	0.000356	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	2.92e-05	0.000356	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	2.43e-05	0.000297	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—melanoma	2.06e-05	0.000251	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—melanoma	1.68e-05	0.000205	CbGpPWpGaD
